David G Ostrow

Psychosocial and Public Health Impacts of New HIV Therapies - Aids Prevention and Mental Health David G Ostrow 2002 edition

Marc Notes: Includes bibliographical references and index. Table of Contents: 1. Combination Antiretroviral Chemotherapy: Shifting Paradigms and Evolving Praxis; K. H. Mayer. 2. Pharmacokinetics of Protease Inhibitors and Drug Interactions with Psychoactive Drugs; S. K. Chuck, et al. 3. Treatment Adherence to HIV Medications: The Achilles Heel of the New Therapeutics; J. G. Rabkin, M. Chesney. 4. Combination Antiretroviral Therapies for HIV: Some Economic Considerations; S. D. Pinkerton, D. R. Holtgrave. 5. Ethical Issues in the Use of New Treatment for HIV; E. Heitman, M. W. Ross. 6. Mental Health Implications of new HIV Treatments; S. C. Kalichman, B. Ramachandran. 7. Practical Prevention Issues; D. G. Ostrow. 8. Postexposure Prophylaxis: A Community Member's Perspectives; M. Shriver. 9. Behavioral Research Needs and Challenges of Nnew Treatments: AIDS as a Chronic Illness; W. Pequegnat, E. Stover. Glossary. Index. Publisher Marketing: AIDS is kind of like life, just speeded up. JavonP., heroinaddictwithAIDS, Bronx, NewYork, 1988 Now I m not so much scared of dying as scared of living. Mike D., heroin addict with AIDS, New Haven, Connecticut, 1998 Within little more than a decade, AIDS has been tranformed from an untreatable, rapidly fatal illness, into a manageable, chronic disease. Most of this tranformation has occurred in the past five years, accelerated by the advent of protease inhibitors and the proven benefits of combination antiretroviral therapy and prophylaxis against opportunistic infections. For people living with HIV/AIDS, these developments have offered unprecedented hope, and also new challenges. As reflected in the quotes above, some of the anxieties and anticipation of premature dying have been replaced by the uncertainties involved in living with a long-term, unpredictable illness. The role of caregivers for people with HIV/AIDS has also changed radically over this time. Earlier in the epidemic, we learned to accompany patients through illness, to bear witness, to advocate, to address issues of death, dying, and - reavement. The arrival of more effective therapy has brought with it new capabi- ties, but also new complexities, raising difficult problems concerning access to care, adherence, and toxicity."

Contributor Bio:  Kalichman, Seth C Kalichman is and assistant professor in the Department of Psychiatry and Mental Health Sciences at the Medical College of Wisconsin. Contributor Bio:  Nattrass, Nicoli Nicoli Nattrass is Professor of Economics and Director of the AIDS and Society Research Unit at the University of Cape Town, and a regular visiting professor at Yale where she teaches courses on development and the AIDS epidemic. She has published widely on macroeconomic policy, inequality, AIDS, and the struggle for antiretroviral treatment. Her work on the economics of preventing the transmission of HIV from mother to child was used in a successful court case launched by South Africa s Treatment Action Campaign against the then government of Thabo Mbeki. In her subsequent research on the role of ideas in shaping South Africa s response to AIDS, she focused on AIDS denialist and AIDS conspiracy beliefs.